<?xml version="1.0" encoding="UTF-8"?>
<p>Our patient was both T- and B-cell-depleted due to the double haploidentical HSCT, conditioning regimens with antithymocyte globulin and rituximab treatment. Without HAdV specific CD4+ helper, CD8+ cytotoxic T cells and inadequate clearance, the HAdV caused a symptomatic viraemia [
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B7" ref-type="bibr">7</xref>]. Other immunocompromised patients (e.g., severe combined immunodeficiency or HIV-patients) might as well benefit from easily accessible drugs with a reasonably safe toxic profile [
 <xref rid="B8" ref-type="bibr">8</xref>].
</p>
